TerminatedNCT00593229
International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
Studying Congenital thrombotic thrombocytopenic purpura
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Northwell Health
- Principal Investigator
- Howard Trachtman, MDSchneider Children's Hospital
- Enrollment
- 6 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2007
Study locations (1)
- Schneider Chldren's Hospital, New Hyde Park, New York, United States
Collaborators
Children's Hospital of Philadelphia · Mario Negri Institute for Pharmacological Research · Icahn School of Medicine at Mount Sinai · University of Virginia · Montreal Children's Hospital of the MUHC · University of Utah · Stollery Children's Hospital · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00593229 on ClinicalTrials.govOther trials for Congenital thrombotic thrombocytopenic purpura
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07513948Daratumumab in Immune-mediated Thrombotic Thrombocytopenic PurpuraFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- RECRUITINGNCT06441578A Survey of Recombinant ADAMTS13 in Participants With Congenital Thrombotic Thrombocytopenic PurpuraTakeda
- RECRUITINGNCT01257269Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)Insel Gruppe AG, University Hospital Bern
See all trials for Congenital thrombotic thrombocytopenic purpura →